Story perspectives

New AI and Blood Tests Transform Mental Health Diagnostics

10/25/2025

37 9

Summary

Story summary

Laguna Diagnostics received a second patent for rapid blood tests using 18-gene biomarker panels to differentiate schizophrenia and bipolar disorder with 88%–96% accuracy, building on a prior patent.
The tests provide objective results that could improve outcomes and reduce misdiagnoses.
An Israeli research team developed an AI model to assess suicide risk in bipolar patients with over 95% accuracy, identifying genetic markers linked to vulnerability and enabling timely intervention.

1 of 1

Story summary

Laguna Diagnostics received a second patent for rapid blood tests using 18-gene biomarker panels to differentiate schizophrenia and bipolar disorder with 88%–96% accuracy, building on a prior patent.
The tests provide objective results that could improve outcomes and reduce misdiagnoses.
An Israeli research team developed an AI model to assess suicide risk in bipolar patients with over 95% accuracy, identifying genetic markers linked to vulnerability and enabling timely intervention.